Form 4 for CHRS Coherus Oncology, Inc.
Accepted 2021-10-19 00:00:00 ET · period of report 2021-10-15 · accession 0001567619-21-018470 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-19 | 2021-10-15 | CHRS | Stilwell McDavid | CFO | S - Sale | $16.80 | -3,507 | 31.6K | -10% | -$58.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-15 | S | D | 3,507 | $16.80 | 31,611 | D | — | — | (F2) Includes 20,000 RSUs. |